Bausch + Lomb Corporation

BLCO Healthcare Medical Instruments & Supplies

Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.

Revenue
+7.34%
EPS
+222.4%
Free cash flow
+182.5%
Total debt
+2.93%

Quarter to September 2026, against a year earlier

19.69 0.23 −1.15%
Market cap
$7.1B
P/E
0.0×
Fwd P/E
749×
Dividend yield
—
F-score
3/9
Altman Z
0.87
Beneish M
−2.52
Dividend safety
n/a

Bausch + Lomb Corporation 10-K filed Feb 18, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed · accepted 5:19 PM ET · Document on sec.gov · Filing index

What changed

Item 7, Management’s Discussion and Analysis, against the 10-K filed Feb 19, 2025: 53 added · 28 removed · 79 modified; 25 with only figures updated